Amicus Therapeutics Inc. (FOLD)
NASDAQ: FOLD
· Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.41
0.13%
After-hours: Aug 15, 2025, 07:55 PM EDT
Amicus Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 158.7M | 181.66M | 213.75M | 233.65M | 209.34M | 209.76M | 246.99M | 263.32M | 211.31M | 160.6M | 148.81M | 277.59M | 235.64M | 233.32M | 245.2M | 385.9M | 176.54M | 184.83M |
Short-Term Investments | 72.3M | 68.92M | 36.19M | 16.11M | 50.73M | 29.84M | 39.21M | 16.98M | 54.32M | 106.51M | 144.78M | 77.11M | 151.2M | 177.88M | 237.3M | 171.06M | 206.53M | 232.6M |
Long-Term Investments | n/a | n/a | n/a | n/a | 3.02M | 3.03M | 3.08M | 2.95M | 3.03M | n/a | 4.3M | 3.94M | 4.22M | -4.93M | 4.26M | -4.9M | -4.9M | -4.9M |
Other Long-Term Assets | 13.37M | 14M | 13.64M | 18.68M | 14.34M | 14.62M | 15.47M | 21.13M | 19.05M | 20.17M | 19.24M | 9M | 8.89M | 25.19M | 20.17M | 22.08M | 21.2M | 20.54M |
Receivables | 105.85M | 88.32M | 101.1M | 98.07M | 85.17M | 76.43M | 87.63M | 73.33M | 63.72M | 68.18M | 66.2M | 52.3M | 52.56M | 52.42M | 52.67M | 51.43M | 49.17M | 44.93M |
Inventory | 154.88M | 132.41M | 118.78M | 115.34M | 81.32M | 60.76M | 59.7M | 56.94M | 51.38M | 27M | 23.82M | 13.27M | 20.88M | 24.32M | 26.82M | 22.07M | 24.09M | 18.8M |
Other Current Assets | 46.28M | 39.49M | 34.91M | 35.31M | 35.15M | 54.44M | 49.53M | 52.69M | 52.1M | 37.41M | 40.21M | 38.26M | 37.37M | 30.96M | 34.85M | 20.08M | 24.18M | 21.73M |
Total Current Assets | 538.01M | 510.8M | 504.74M | 498.47M | 461.7M | 431.24M | 483.06M | 463.26M | 432.82M | 399.7M | 423.82M | 458.54M | 497.64M | 518.9M | 596.83M | 650.54M | 480.5M | 502.89M |
Property-Plant & Equipment | 50.56M | 50.86M | 51.66M | 53.58M | 53.77M | 55.42M | 57.98M | 60.58M | 58.28M | 59.89M | 60.31M | 62.32M | 64.1M | 62.05M | 63.08M | 63.26M | 64.39M | 65.81M |
Goodwill & Intangibles | 213.37M | 214.19M | 215M | 215.82M | 216.65M | 217.47M | 218.29M | 219.12M | 219.94M | 220.76M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M |
Total Long-Term Assets | 277.3M | 279.04M | 280.3M | 288.08M | 287.78M | 290.55M | 294.82M | 300.83M | 297.27M | 300.82M | 300.35M | 300.99M | 302.95M | 308.04M | 308.31M | 306.13M | 306.39M | 307.14M |
Total Assets | 815.3M | 789.84M | 785.03M | 786.56M | 749.48M | 721.79M | 777.88M | 764.08M | 730.09M | 700.52M | 724.17M | 759.53M | 800.59M | 826.94M | 905.14M | 956.67M | 786.89M | 810.03M |
Account Payables | 13.89M | 14.45M | 12.95M | 13.48M | 32.06M | 9.21M | 15.12M | 23.15M | 13.52M | 24.96M | 15.41M | 12.05M | 23.11M | 22.91M | 21.51M | 24.47M | 13.76M | 16.11M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 12.43M | n/a | n/a | n/a | 4.94M | 4.93M | -7.54M | n/a | 4.93M | n/a | n/a | n/a |
Short-Term Debt | 8.61M | n/a | n/a | 8.54M | 8.11M | 8.27M | 8.32M | 7.76M | 7.84M | n/a | n/a | 7.54M | 7.54M | 7.25M | n/a | 7.17M | 7.11M | 6.76M |
Other Current Liabilities | 145.14M | 138.44M | 49.69M | 127.58M | -8.11M | -8.27M | 85.18M | -7.76M | -7.84M | n/a | 83.41M | -7.54M | -7.54M | -7.25M | 86.64M | -7.17M | -7.11M | -6.76M |
Total Current Liabilities | 167.65M | 152.89M | 148.7M | 158.14M | 168.07M | 142.1M | 167.69M | 169.45M | 159.24M | 138.38M | 139.02M | 164.65M | 164.63M | 129.7M | 145.97M | 121.1M | 111.99M | 99.65M |
Long-Term Debt | 434.7M | 390.71M | 390.11M | 389.49M | 388.94M | 388.39M | 387.86M | 446.52M | 444.33M | 392.66M | 391.99M | 443.33M | 443.5M | 440.45M | 389.36M | 432.21M | 434.63M | 434.22M |
Other Long-Term Liabilities | 8.65M | 52.68M | 7.1M | 13.48M | 12.95M | 12.77M | 13.28M | -37.59M | -36.02M | 15.55M | 13.6M | -37.96M | -38.73M | -37.22M | 14.15M | -21.66M | -22.74M | -24.06M |
Total Long-Term Liabilities | 443.35M | 443.39M | 442.29M | 449.59M | 448.89M | 448.99M | 450.02M | 461.39M | 459.28M | 459.56M | 462.1M | 462.31M | 462.54M | 458.62M | 451.8M | 458.94M | 460.99M | 459.49M |
Total Liabilities | 611M | 596.28M | 590.99M | 607.73M | 616.96M | 591.1M | 617.71M | 630.85M | 618.51M | 597.95M | 601.12M | 626.96M | 627.16M | 588.32M | 597.77M | 580.05M | 572.98M | 559.14M |
Total Debt | 443.31M | 443.47M | 443.64M | 444.66M | 444.06M | 444.49M | 445.06M | 454.29M | 452.17M | 452.01M | 452.12M | 450.87M | 451.04M | 447.71M | 440.13M | 439.39M | 441.74M | 440.98M |
Common Stock | 3.02M | 3.02M | 2.94M | 2.94M | 2.92M | 2.92M | 2.92M | 2.89M | 2.86M | 2.82M | 2.81M | 2.81M | 2.81M | 2.81M | 2.81M | 2.81M | 2.69M | 2.68M |
Retained Earnings | -2.79B | -2.76B | -2.74B | -2.75B | -2.75B | -2.73B | -2.68B | -2.65B | -2.63B | -2.59B | -2.53B | -2.48B | -2.44B | -2.38B | -2.3B | -2.21B | -2.16B | -2.11B |
Comprehensive Income | n/a | n/a | 5.09M | 24.97M | 8.87M | 6.71M | 5.31M | -6.77M | 4.16M | -6.74M | -12.11M | -39.08M | -17.24M | -1.03M | 4.98M | 6.43M | 9.08M | 8.84M |
Shareholders Equity | 204.3M | 193.56M | 194.04M | 178.82M | 132.52M | 130.69M | 160.17M | 133.24M | 111.58M | 102.57M | 123.05M | 132.56M | 173.43M | 238.62M | 307.37M | 376.63M | 213.91M | 250.9M |
Total Investments | n/a | 68.92M | 36.19M | 16.11M | 53.75M | 32.88M | 42.29M | 16.98M | 54.32M | 106.51M | 144.78M | 77.11M | 151.2M | 177.88M | 237.3M | 171.06M | 206.53M | 232.6M |